The role of eating styles in diabetes control
New research reveals that patients who eat in response to food cues lose more weight on GLP-1 therapy,…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Are GLP-1 drugs safe for women planning pregnancy?
New national data reveal a sharp rise in GLP-1 prescriptions for young women, but low contraception use leaves…
Low FODMAP diet increases GLP-1 and relieves IBS symptoms
A 12-week low FODMAP diet not only eased pain, bloating, and diarrhea in IBS patients but also raised…
GIPR signaling opens brain’s gate for GLP-1 weight-loss therapy
A new study uncovers how GIPR signaling in brain cells helps GLP-1 weight-loss drugs bypass the blood-brain barrier…
Brain’s energy control map offers blueprint for next-gen weight loss therapies
A deep dive into the brain’s command center for hunger shows how decoding its circuits could transform the…
Metformin’s blood sugar control starts in the brain, not just the liver, study finds
Scientists uncover how low-dose metformin targets brain pathways to lower blood sugar, opening fresh avenues for safer and…
Weight regain observed in patients after ending obesity drug treatment
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their…